Early SGLT2i therapy in patients with T2DM and ACS results in reduction in cardiovascular and renal outcomes- a propensity score matched multi-model retrospective registry analysis
29 August 2025 (07:00 - 18:00)
Organised by: 
About the speaker
Hull University Teaching Hospitals NHS Trust, Hull (United Kingdom of Great Britain & Northern Ireland)
5 More presentations in this session
Professor J. Gao (Tianjin, CN)
Doctor N. Espinola-Zavaleta (Mexico City, MX)
Mrs B. Gustafsson (Turku, FI)
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
